Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 544

1.

Factors associated with missed assessments in a 2-year longitudinal study of acute respiratory distress syndrome survivors.

Heins SE, Wozniak AW, Colantuoni E, Sepulveda KA, Mendez-Tellez PA, Dennison-Himmelfarb C, Needham DM, Dinglas VD.

BMC Med Res Methodol. 2018 Jun 15;18(1):55. doi: 10.1186/s12874-018-0508-8.

2.

Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials-State of the Art.

Wozniak A, Grinholc M.

Front Microbiol. 2018 May 8;9:930. doi: 10.3389/fmicb.2018.00930. eCollection 2018. Review.

3.

Risk of Second Lung Cancer in Patients With Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results Data.

Wozniak AJ, Schwartz AG.

J Thorac Oncol. 2018 Jun;13(6):e106-e107. doi: 10.1016/j.jtho.2018.04.009. No abstract available.

PMID:
29793650
4.

Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC).

Gadgeel SM, Pennell NA, Fidler MJ, Halmos B, Bonomi P, Stevenson J, Schneider B, Sukari A, Ventimiglia J, Chen W, Galasso C, Wozniak A, Boerner J, Kalemkerian GP.

J Thorac Oncol. 2018 May 15. pii: S1556-0864(18)30600-2. doi: 10.1016/j.jtho.2018.05.002. [Epub ahead of print]

PMID:
29775808
5.

The Oxidant-Antioxidant Equilibrium and Inflammatory Process Indicators after an Exercise Test on the AlterG Antigravity Treadmill in Young Amateur Female Athletes.

Sielski Ł, Sutkowy P, Skopowska A, Pawlak-Osińska K, Augustyńska Z, Hewelt K, Drapała R, Woźniak A.

Oxid Med Cell Longev. 2018 Mar 25;2018:3484159. doi: 10.1155/2018/3484159. eCollection 2018.

6.

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Schöffski P, Wozniak A, Stacchiotti S, Rutkowski P, Blay JY, Lindner LH, Strauss SJ, Anthoney A, Duffaud F, Richter S, Grünwald V, Leahy MG, Reichardt P, Sufliarsky J, van der Graaf WT, Sciot R, Debiec-Rychter M, van Cann T, Marréaud S, Lia M, Raveloarivahy T, Collette L, Bauer S.

Ann Oncol. 2018 May 5. doi: 10.1093/annonc/mdx823. [Epub ahead of print] No abstract available.

PMID:
29741569
7.

Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.

Wozniak A, Scioscia N, García PC, Dale JB, Paillavil BA, Legarraga P, Salazar-Echegarai FJ, Bueno SM, Kalergis AM.

Microbiol Immunol. 2018 Jun;62(6):395-404. doi: 10.1111/1348-0421.12595. Epub 2018 Jun 11.

PMID:
29704396
8.

Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

Schöffski P, Sufliarsky J, Gelderblom H, Blay JY, Strauss SJ, Stacchiotti S, Rutkowski P, Lindner LH, Leahy MG, Italiano A, Isambert N, Debiec-Rychter M, Sciot R, Van Cann T, Marréaud S, Nzokirantevye A, Collette S, Wozniak A.

Lancet Respir Med. 2018 Jun;6(6):431-441. doi: 10.1016/S2213-2600(18)30116-4. Epub 2018 Apr 15.

PMID:
29669701
9.

Comparing Treatment Strategies for Stage I Small-cell lung Cancer.

Paximadis P, Beebe-Dimmer JL, George J, Schwartz AG, Wozniak A, Gadgeel S.

Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30059-7. doi: 10.1016/j.cllc.2018.03.017. [Epub ahead of print]

PMID:
29656869
10.

The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.

Schöffski P, Wozniak A, Leahy MG, Aamdal S, Rutkowski P, Bauer S, Richter S, Grünwald V, Debiec-Rychter M, Sciot R, Geoerger B, Marréaud S, Collette S, Nzokirantevye A, Strauss SJ.

Eur J Cancer. 2018 May;94:156-167. doi: 10.1016/j.ejca.2018.02.011. Epub 2018 Mar 20.

PMID:
29567632
11.

Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.

van Cann T, Cornillie J, Wozniak A, Debiec-Rychter M, Sciot R, Hompes D, Vergote I, Schöffski P.

Oncol Res Treat. 2018;41(4):206-213. doi: 10.1159/000486419. Epub 2018 Mar 23.

PMID:
29562223
12.

The risk of second primary lung cancer: an unsolved dilemma.

Wozniak AJ, Schwartz AG.

Transl Lung Cancer Res. 2018 Feb;7(Suppl 1):S54-S56. doi: 10.21037/tlcr.2018.01.13. No abstract available.

13.

Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.

Verbiest A, Lambrechts D, Van Brussel T, Couchy G, Wozniak A, Méjean A, Lerut E, Oudard S, Verkarre V, Job S, de Reynies A, Machiels JP, Patard JJ, Zucman-Rossi J, Beuselinck B.

Clin Genitourin Cancer. 2018 Feb 5. pii: S1558-7673(18)30072-7. doi: 10.1016/j.clgc.2018.01.013. [Epub ahead of print]

PMID:
29503246
14.

Ultrasonography of uterine leiomyomas.

Woźniak A, Woźniak S.

Prz Menopauzalny. 2017 Dec;16(4):113-117. doi: 10.5114/pm.2017.72754. Epub 2017 Dec 30. Review.

15.

Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy.

Verbiest A, Couchy G, Job S, Caruana L, Lerut E, Oyen R, de Reyniès A, Tosco L, Joniau S, Van Poppel H, Van Raemdonck D, Van Den Eynde K, Wozniak A, Zucman-Rossi J, Beuselinck B.

Eur Urol. 2018 Feb 17. pii: S0302-2838(18)30097-6. doi: 10.1016/j.eururo.2018.01.042. [Epub ahead of print]

PMID:
29463434
16.

Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.

Waligora M, Bala MM, Koperny M, Wasylewski MT, Strzebonska K, Jaeschke RR, Wozniak A, Piasecki J, Sliwka A, Mitus JW, Polak M, Nowis D, Fergusson D, Kimmelman J.

PLoS Med. 2018 Feb 20;15(2):e1002505. doi: 10.1371/journal.pmed.1002505. eCollection 2018 Feb.

17.

Identifying oil/marine snow associations in mesocosm simulations of the Deepwater Horizon oil spill event using solid-state 13C NMR spectroscopy.

Hatcher PG, Obeid W, Wozniak AS, Xu C, Zhang S, Santschi PH, Quigg A.

Mar Pollut Bull. 2018 Jan;126:159-165. doi: 10.1016/j.marpolbul.2017.11.004. Epub 2017 Nov 9.

PMID:
29421083
18.

Adherence to nutrition guidelines in patients with cardiovascular diseases (CVD) as a secondary prevention

Woźniak A, Krótki M, Anyżewska A, Górnicka M, Wawrzyniak A.

Rocz Panstw Zakl Hig. 2017;68(4):401-407.

19.

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting.

Verbiest A, Couchy G, Job S, Zucman-Rossi J, Caruana L, Lerut E, Oyen R, de Reyniès A, Laguerre B, Rioux-Leclercq N, Wozniak A, Joniau S, Van Poppel H, Van Den Eynde K, Beuselinck B.

Clin Genitourin Cancer. 2018 Jun;16(3):e605-e612. doi: 10.1016/j.clgc.2017.10.017. Epub 2017 Nov 7.

PMID:
29239846
20.

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.

Schöffski P, Wozniak A, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Gelderblom H, Italiano A, Lindner LH, Hennig I, Strauss S, Zakotnik B, Anthoney A, Albiges L, Blay JY, Reichardt P, Sufliarsky J, van der Graaf WTA, Debiec-Rychter M, Sciot R, Van Cann T, Marréaud S, Raveloarivahy T, Collette S, Stacchiotti S.

Ann Oncol. 2018 Mar 1;29(3):758-765. doi: 10.1093/annonc/mdx774.

PMID:
29216400
21.

[Evaluation of Xpert® MTB/RIF technique for Mycobacterium tuberculosis complex detection in extra-respiratory specimens].

García P, Balcells ME, Castillo C, Miranda C, Geoffroy E, Román JC, Wozniak A.

Rev Chilena Infectol. 2017 Aug;34(4):333-339. doi: 10.4067/s0716-10182017000400333. Spanish.

22.

[Test evaluation and strategy proposal to detect and to characterize carbapenemase-producing gram negative bacilli].

Muñoz C, Zumarán C, González T, Wozniak A, Castillo C, García P.

Rev Chilena Infectol. 2017 Aug;34(4):326-332. doi: 10.4067/s0716-10182017000400326. Spanish.

23.

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.

Schöffski P, Wozniak A, Escudier B, Rutkowski P, Anthoney A, Bauer S, Sufliarsky J, van Herpen C, Lindner LH, Grünwald V, Zakotnik B, Lerut E, Debiec-Rychter M, Marréaud S, Lia M, Raveloarivahy T, Collette S, Albiges L.

Eur J Cancer. 2017 Dec;87:147-163. doi: 10.1016/j.ejca.2017.10.014. Epub 2017 Nov 14.

PMID:
29149761
24.

Primary myxoid mesenchymal tumour with intracranial location: report of a case with a EWSR1-ATF1 fusion.

Sciot R, Jacobs S, Calenbergh FV, Demaerel P, Wozniak A, Debiec-Rychter M.

Histopathology. 2018 Apr;72(5):880-883. doi: 10.1111/his.13437. Epub 2018 Jan 11. No abstract available.

PMID:
29143432
25.

Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.

Szewczyk-Golec K, Rajewski P, Gackowski M, Mila-Kierzenkowska C, Wesołowski R, Sutkowy P, Pawłowska M, Woźniak A.

Oxid Med Cell Longev. 2017;2017:8494107. doi: 10.1155/2017/8494107. Epub 2017 Sep 21.

26.

The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.

Streb W, Mitręga K, Szymała M, Woźniak A, Podolecki T, Kalarus Z.

Kardiol Pol. 2018;76(2):433-439. doi: 10.5603/KP.a2017.0206. Epub 2017 Nov 13.

27.

New targets and therapies for gastrointestinal stromal tumors.

Wozniak A, Gebreyohannes YK, Debiec-Rychter M, Schöffski P.

Expert Rev Anticancer Ther. 2017 Dec;17(12):1117-1129. doi: 10.1080/14737140.2017.1400386. Review.

PMID:
29110548
28.

A precision therapy against cancers driven by KIT/PDGFRA mutations.

Evans EK, Gardino AK, Kim JL, Hodous BL, Shutes A, Davis A, Zhu XJ, Schmidt-Kittler O, Wilson D, Wilson K, DiPietro L, Zhang Y, Brooijmans N, LaBranche TP, Wozniak A, Gebreyohannes YK, Schöffski P, Heinrich MC, DeAngelo DJ, Miller S, Wolf B, Kohl N, Guzi T, Lydon N, Boral A, Lengauer C.

Sci Transl Med. 2017 Nov 1;9(414). pii: eaao1690. doi: 10.1126/scitranslmed.aao1690.

PMID:
29093181
29.

The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors.

Mikuła-Pietrasik J, Uruski P, Szubert S, Maksin K, Moszyński R, Szpurek D, Woźniak A, Sajdak S, Tykarski A, Książek K.

Biomed Res Int. 2017;2017:2592496. doi: 10.1155/2017/2592496. Epub 2017 Sep 20.

30.

Comparative Efficacy of Topical Pertmehrin, Crotamiton and Sulfur Ointment in Treatment of Scabies.

Mila-Kierzenkowska C, Woźniak A, Krzyżyńska-Malinowska E, Kałużna L, Wesołowski R, Poćwiardowski W, Owcarz M.

J Arthropod Borne Dis. 2017 Mar 14;11(1):1-9. eCollection 2017 Mar.

31.

Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ.

J Thorac Oncol. 2018 Jan;13(1):46-53. doi: 10.1016/j.jtho.2017.09.1964. Epub 2017 Oct 5.

PMID:
28989038
32.

Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4.

Matus V, Valenzuela JG, Hidalgo P, Pozo LM, Panes O, Wozniak A, Mezzano D, Pereira J, Sáez CG.

PLoS One. 2017 Sep 28;12(9):e0185431. doi: 10.1371/journal.pone.0185431. eCollection 2017.

33.

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Schöffski P, Wozniak A, Stacchiotti S, Rutkowski P, Blay JY, Lindner LH, Strauss SJ, Anthoney A, Duffaud F, Richter S, Grünwald V, Leahy MG, Reichardt P, Sufliarsky J, van der Graaf WT, Sciot R, Debiec-Rychter M, van Cann T, Marréaud S, Lia M, Raveloarivahy T, Collette L, Bauer S.

Ann Oncol. 2017 Dec 1;28(12):3000-3008. doi: 10.1093/annonc/mdx527.

PMID:
28950372
34.

EPR Oximetry Sensor-Developing a TAM Derivative for In Vivo Studies.

Boś-Liedke A, Walawender M, Woźniak A, Flak D, Gapiński J, Jurga S, Kucińska M, Plewiński A, Murias M, Elewa M, Lampp L, Imming P, Tadyszak K.

Cell Biochem Biophys. 2018 Jun;76(1-2):19-28. doi: 10.1007/s12013-017-0824-3. Epub 2017 Sep 4.

35.

ZnO@Gd2O3 core/shell nanoparticles for biomedical applications: Physicochemical, in vitro and in vivo characterization.

Woźniak A, Grześkowiak BF, Babayevska N, Zalewski T, Drobna M, Woźniak-Budych M, Wiweger M, Słomski R, Jurga S.

Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:603-615. doi: 10.1016/j.msec.2017.07.009. Epub 2017 Jul 11.

PMID:
28866207
36.

The Influence of Lead on Generation of Signalling Molecules and Accumulation of Flavonoids in Pea Seedlings in Response to Pea Aphid Infestation.

Woźniak A, Drzewiecka K, Kęsy J, Marczak Ł, Narożna D, Grobela M, Motała R, Bocianowski J, Morkunas I.

Molecules. 2017 Aug 24;22(9). pii: E1404. doi: 10.3390/molecules22091404.

37.

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.

West HL, Moon J, Wozniak AJ, Mack P, Hirsch FR, Bury MJ, Kwong M, Nguyen DD, Moore DF, Miao J, Redman M, Kelly K, Gandara DR.

Clin Lung Cancer. 2018 Jan;19(1):84-92. doi: 10.1016/j.cllc.2017.06.016. Epub 2017 Jul 6.

38.

In vitro genotoxicity and cytotoxicity of polydopamine-coated magnetic nanostructures.

Woźniak A, Walawender M, Tempka D, Coy E, Załęski K, Grześkowiak BF, Mrówczyński R.

Toxicol In Vitro. 2017 Oct;44:256-265. doi: 10.1016/j.tiv.2017.07.022. Epub 2017 Jul 25.

PMID:
28754539
39.

Locomotor activity of adult Dermacentor reticulatus ticks (Ixodida: Ixodidae) in natural conditions.

Buczek A, Zając Z, Woźniak A, Kulina D, Bartosik K.

Ann Agric Environ Med. 2017 May 11;24(2):271-275. doi: 10.5604/12321966.1230736.

40.

Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.

Mikuła-Pietrasik J, Uruski P, Pakuła M, Maksin K, Szubert S, Woźniak A, Naumowicz E, Szpurek D, Tykarski A, Książek K.

Free Radic Biol Med. 2017 Sep;110:270-279. doi: 10.1016/j.freeradbiomed.2017.06.015. Epub 2017 Jun 24.

PMID:
28652056
41.

First detection of porcine circovirus type 3 on commercial pig farms in Poland.

Stadejek T, Woźniak A, Miłek D, Biernacka K.

Transbound Emerg Dis. 2017 Oct;64(5):1350-1353. doi: 10.1111/tbed.12672. Epub 2017 Jun 26.

PMID:
28649803
42.

Assessment of differences in nutrients consumption in women diagnosed with osteoporosis as compared to a healthy control group

Wawrzyniak A, Klimczyk P, Woźniak A, Anyżewska A, Leonkiewicz M.

Rocz Panstw Zakl Hig. 2017;68(2):143-149.

43.

In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models.

Cornillie J, Wozniak A, Pokreisz P, Casazza A, Vreys L, Wellens J, Vanleeuw U, Gebreyohannes YK, Debiec-Rychter M, Sciot R, Hompes D, Schöffski P.

Mol Cancer Ther. 2017 Aug;16(8):1566-1575. doi: 10.1158/1535-7163.MCT-16-0832. Epub 2017 May 31.

PMID:
28566438
44.

Influence of Cytochrome P450, ABC and SLC Gene Polymorphisms on Imatinib Therapy Outcome of Patients with Gastrointestinal Stromal Tumours (GIST).

Wasielewski K, Wasag B, Wozniak A, Pikiel J, Kowalik A, Osuch C, Bylina E, Siedlecki JA, Rutkowski P, Limon J.

Folia Biol (Praha). 2017;63(2):78-83.

45.

Effect of Propionibacterium acnes (PA) injection on intervertebral disc degeneration in a rat model: Does it mimic modic changes?

Zamora T, Palma J, Andia M, Garcia P, Wozniak A, Solar A, Campos M.

Orthop Traumatol Surg Res. 2017 Sep;103(5):795-799. doi: 10.1016/j.otsr.2017.04.005. Epub 2017 May 25.

PMID:
28552835
46.

Renal cell carcinoma metastasizing to pancreatic neuroendocrine neoplasm - the second case described in the world literature.

Bednarek-Rajewska K, Zalewski P, Bręborowicz D, Woźniak A.

Pol J Pathol. 2017;68(1):82-85. doi: 10.5114/pjp.2017.67621.

47.

Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications.

Woźniak A, Malankowska A, Nowaczyk G, Grześkowiak BF, Tuśnio K, Słomski R, Zaleska-Medynska A, Jurga S.

J Mater Sci Mater Med. 2017 Jun;28(6):92. doi: 10.1007/s10856-017-5902-y. Epub 2017 May 11.

PMID:
28497362
48.

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.

Langer CJ, Paz-Ares LG, Wozniak AJ, Gridelli C, de Marinis F, Pujol JL, San Antonio B, Chen J, Liu J, Oton AB, Visseren-Grul C, Scagliotti GV.

Clin Lung Cancer. 2017 Sep;18(5):489-496. doi: 10.1016/j.cllc.2017.04.003. Epub 2017 Apr 12.

PMID:
28479368
49.

Importance of adhesins in the recurrence of pharyngeal infections caused by Streptococcus pyogenes.

Wozniak A, Scioscia N, Geoffroy E, Ponce I, García P.

J Med Microbiol. 2017 Apr;66(4):517-525. doi: 10.1099/jmm.0.000464.

PMID:
28463664
50.

Volatile organic compounds in gastrointestinal stromal tumour tissue originating from patient-derived xenografts.

Wawrzyniak R, Woźniak A, Gebreyohannes YK, Dykcik B, Schöffski P, Markuszewski MJ.

J Breath Res. 2017 Jun 29;11(3):037101. doi: 10.1088/1752-7163/aa6d87.

PMID:
28416775

Supplemental Content

Loading ...
Support Center